CEO Ben Kaplan sits down with Brandon Colwell to give an overview of the company and explain what it is that sets them apart from their competition. How they began, and where their path to success is being forged are all apart of this interview.
"The keys to healing are having a better snapshot (we call this data) inside of the who, what, when, where, how, and why you behave the way you do. Ehave is a data-driven ecosystem for the digital assessment and remediation of the most common mental health disorders faced by children, adolescents, and adults."
As mental health and the treatment through psychedelics has come more to light in the recent years, the aspect of collecting data in order to treat patients better has and will continue to play a crucial role in the process of diagnosis, treatment, and healing and EHAVE is planning to align themselves with sector leaders in order to build their database and relationship surrounding those data sets for the empowerment of patients.
EHAVE is a Canadian company listed in the US, specializing in the collection of data. They plan on concentrating on companies with new delivery systems, building those relationships with companies that run psychedelic retreats to capture the data sets in order to offer them out. Partnering with patients to empower them by using their own data giving them an abundance of blanket data for psychedelics, mental health, depression, anxiety, and retreats.
A few very interesting points in the interview that we feel you may want to pay special attention to are...
(5:15) Ben explains what differentiates EHAVE from their competitors
(8:05) Their path to revenue
(10:07) The planned purchase of the telemedicine platform "MDLink"
For more information on this company, please visit https://www.ehave.com/